Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hauke Walter

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of the International AIDS Society|November 15, 2014
Resistance remains a problem in treatment failureMartin Obermeier, Robert Ehret, Andreas Wienbreyer, et al.
Journal of the International AIDS Society|November 14, 2014
Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatmentRobert Ehret, Hauke Walter, Patrick Ingiliz, et al.
Journal of Virological Methods|January 2, 2007
Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell culturesMonika Tschochner, Eva Schwingel, Christine Thein, et al.
AIDS (London, England)|June 24, 2003
Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samplesTanja Schnell, Barbara Schmidt, Gitta Moschik, et al.
Journal of the International AIDS Society|November 15, 2014
New dolutegravir resistance pattern identified in a patient failing antiretroviral therapyAndreas Carganico, Stefan Dupke, Robert Ehret, et al.
Journal of Virology|May 2, 2008
Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant human immunodeficiency virus type 1 reverse transcriptase variantsStefanie Andrea Knoepfel, Nadine Christina Salisch, Peter Michael Huelsmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotypeNiko Beerenwinkel, Barbara Schmidt, Hauke Walter, et al.
Bioinformatics (Oxford, England)|July 12, 2003
Methods for optimizing antiviral combination therapiesNiko Beerenwinkel, Thomas Lengauer, Martin Däumer, et al.
Antiviral Research|August 4, 2006
Antiviral activity of Arthrospira-derived spirulan-like substancesSabine Rechter, Tanja König, Sabrina Auerochs, et al.
Nucleic Acids Research|June 26, 2003
Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypesNiko Beerenwinkel, Martin Däumer, Mark Oette, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of the International AIDS Society|November 15, 2014
Resistance remains a problem in treatment failureMartin Obermeier, Robert Ehret, Andreas Wienbreyer, et al.
Journal of the International AIDS Society|November 14, 2014
Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatmentRobert Ehret, Hauke Walter, Patrick Ingiliz, et al.
Journal of Virological Methods|January 2, 2007
Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell culturesMonika Tschochner, Eva Schwingel, Christine Thein, et al.
AIDS (London, England)|June 24, 2003
Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samplesTanja Schnell, Barbara Schmidt, Gitta Moschik, et al.
Journal of the International AIDS Society|November 15, 2014
New dolutegravir resistance pattern identified in a patient failing antiretroviral therapyAndreas Carganico, Stefan Dupke, Robert Ehret, et al.
Journal of Virology|May 2, 2008
Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant human immunodeficiency virus type 1 reverse transcriptase variantsStefanie Andrea Knoepfel, Nadine Christina Salisch, Peter Michael Huelsmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotypeNiko Beerenwinkel, Barbara Schmidt, Hauke Walter, et al.
Bioinformatics (Oxford, England)|July 12, 2003
Methods for optimizing antiviral combination therapiesNiko Beerenwinkel, Thomas Lengauer, Martin Däumer, et al.
Antiviral Research|August 4, 2006
Antiviral activity of Arthrospira-derived spirulan-like substancesSabine Rechter, Tanja König, Sabrina Auerochs, et al.
Nucleic Acids Research|June 26, 2003
Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypesNiko Beerenwinkel, Martin Däumer, Mark Oette, et al.
Pageof 4